Interim results from a post-marketing observational safety study (PASS) of levofloxacin inhalation solution in patients with cystic fibrosis
EUROPEAN RESPIRATORY JOURNAL(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
EUROPEAN RESPIRATORY JOURNAL(2023)